Association between serum soluble Toll-like receptor 2 and 4 and the risk of breast cancer.

In conclusion, sTLR2 and sTLR4 may be potential biomarkers of breast cancer susceptibility. PMID: 33414918 [PubMed]
Source: Clinical Breast Cancer - Category: Cancer & Oncology Authors: Tags: Mol Clin Oncol Source Type: research